Central nervous system immune surveillance: on natalizumab, dendritic cells, and dangerous immune privilege
- PMID: 19064742
- DOI: 10.1001/archneur.65.12.1566
Central nervous system immune surveillance: on natalizumab, dendritic cells, and dangerous immune privilege
Comment on
-
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.Arch Neurol. 2008 Dec;65(12):1596-603. doi: 10.1001/archneur.65.12.noc80051. Epub 2008 Oct 13. Arch Neurol. 2008. PMID: 18852339 Clinical Trial.

